What it sells
Next-generation DNA synthesis using enzymes
Business model breakdown
Buyer: who owns the budget?
UnverifiedResearch scientists and biotech/synthetic biology labs ordering DNA.
Trigger: what makes them buy now?
Complex sequences (repeats, high/low GC, secondary structure) that other vendors cannot build or deliver late.
Workflow: what inputs become what output?
Customer submits sequence online, Ansa synthesizes clonal DNA enzymatically (100 bp-7.5 kb, XL up to 50 kb) and ships sequence-verified constructs, replacing assembly and multi-vendor troubleshooting.
Economics: what it saves and how it charges
Per-base-pair product sales of synthesized DNA with delivery and sequence-perfect guarantees.
Distribution: how it reaches customers
Online ordering ("Order Now"), shipped globally from the USA.
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| — | Y Combinator Winter 2020 | — | Y Combinator | ycombinator.com |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-12.